Adicet Bio - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAdicet Bio

Adicet Bio(ACET)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

immune system diseases

,

autoimmune diseases

,

drug interactions

,

,

hepatic insufficiency

,

autosomal recessive polycystic kidney

,

biological availability

,

,

communicable diseases

,

pneumococcal infections

,

amyotrophic lateral sclerosis

,

motor neuron disease

,

,

colorectal neoplasms

,

,

meningococcal infections

,

brain neoplasms

,

,

,

healthy volunteers/patients

,

polycystic kidney diseases

,

,

neoplasm metastasis

,

prostatic neoplasms

,

multiple myeloma

,

plasma cell neoplasms

,

,

systemic scleroderma

,

diffuse scleroderma

,

,

pneumococcal pneumonia

,

,

autosomal dominant polycystic kidney

,

,

kidney diseases

,

,

myeloid leukemia acute

,

myeloid leukemia

,

pancreatic neoplasms

,

human influenza

,

,

,

,

adenocarcinoma of lung

,

ovarian epithelial carcinoma

,

b-cell chronic lymphocytic leukemia

,

prolymphocytic leukemia

,

lymphoid leukemia

,

,

,

,

,

,

idiopathic pulmonary fibrosis

,

pulmonary fibrosis

,

second primary neoplasms

,

meningeal carcinomatosis

,

meningococcal meningitis

,

bronchiolitis obliterans

,

,

,

urinary bladder neoplasms

,

type 1 diabetes mellitus

,

,

bile duct neoplasms

,

esophageal neoplasms

,

hypersensitivity

,

peanut hypersensitivity

,

allergic rhinitis

,

,

acquired immunodeficiency syndrome

,

squamous cell neoplasms

,

,

alpha 1-antitrypsin deficiency

,

pulmonary emphysema

,

non-small-cell lung carcinoma

,

,

,

breast neoplasms

,

,

,

,

ovarian neoplasms

,

,

,

,

,

,

,

,

haemophilus influenzae type b

,

hepatocellular carcinoma

,

liver neoplasms

,

kidney transplantation

,

graft rejection

,

,

graft vs host disease

,

bronchiolitis obliterans syndrome

,

diabetes mellitus

,

type 2 diabetes mellitus

,

,

atrial fibrillation

,

coronary artery disease

,

influenza in birds

,

,

multiple sclerosis

,

,

,

,

,

orthomyxoviridae

,

,

communicable diseases

,

infectious myxomatosis

,

h1n1 subtype influenza a virus

,

,

,

,

,

viral hemorrhagic fevers

,

,

,

,

,

,

,

meningococcal infections

,

,

haemophilus influenzae type b

,

inactivated vaccines

,

,

human influenza

,

orthomyxoviridae infections

,

healthy volunteers/patients

,

,

,

myocardial infarction

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

,

,

,

immune system diseases

,

pregnancy complications

,

,

toxicological phenomena

,

,

respiratory syncytial virus infections

,

,

,

,

atrial fibrillation

,

cardiovascular diseases

,

coronary disease

,

cardiac arrhythmias

,

,

,

diabetes mellitus

,

respiratory tract infections

,

inferior wall myocardial infarction

,

severe acute respiratory syndrome

,

behavior and behavior mechanisms

,

h7n9 subtype influenza a virus

,

influenza in birds

,

h5n1 subtype influenza a virus

,

chronic disease

,

,

orthomyxoviridae

,

,

,

,

meningococcal infections

,

human influenza

,

h1n1 subtype influenza a virus

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

pneumococcal infections

,

haemophilus infections

,

influenza a virus

respiratory tract infections

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use